KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Net Income (2016 - 2025)

Historic Net Income for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to $3.7 billion.

  • Gsk's Net Income rose 446187.52% to $3.7 billion in Q3 2025 from the same period last year, while for Dec 2025 it was $9.7 billion, marking a year-over-year increase of 1210.01%. This contributed to the annual value of $13.2 billion for FY2022, which is 50915.79% up from last year.
  • Per Gsk's latest filing, its Net Income stood at $3.7 billion for Q3 2025, which was up 446187.52% from $2.8 billion recorded in Q2 2025.
  • Gsk's 5-year Net Income high stood at $11.9 billion for Q3 2022, and its period low was $81.9 million during Q3 2024.
  • In the last 5 years, Gsk's Net Income had a median value of $2.1 billion in 2024 and averaged $2.5 billion.
  • In the last 5 years, Gsk's Net Income tumbled by 9684.46% in 2024 and then skyrocketed by 446187.52% in 2025.
  • Gsk's Net Income (Quarter) stood at $687.5 million in 2021, then grew by 6.63% to $733.1 million in 2022, then surged by 687.27% to $5.8 billion in 2023, then decreased by 24.92% to $4.3 billion in 2024, then decreased by 13.82% to $3.7 billion in 2025.
  • Its Net Income was $3.7 billion in Q3 2025, compared to $2.8 billion in Q2 2025 and $3.1 billion in Q1 2025.